ES2530623T3 - Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica - Google Patents

Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica Download PDF

Info

Publication number
ES2530623T3
ES2530623T3 ES11185914T ES11185914T ES2530623T3 ES 2530623 T3 ES2530623 T3 ES 2530623T3 ES 11185914 T ES11185914 T ES 11185914T ES 11185914 T ES11185914 T ES 11185914T ES 2530623 T3 ES2530623 T3 ES 2530623T3
Authority
ES
Spain
Prior art keywords
base
tiles
vertical blade
indazolmethoxyalkanoic
prepare
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11185914T
Other languages
English (en)
Spanish (es)
Inventor
Angelo Guglielmotti
Giuseppe Biondi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2530623T3 publication Critical patent/ES2530623T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mixers Of The Rotary Stirring Type (AREA)
ES11185914T 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica Active ES2530623T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002254A ITMI20062254A1 (it) 2006-11-24 2006-11-24 Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca

Publications (1)

Publication Number Publication Date
ES2530623T3 true ES2530623T3 (es) 2015-03-04

Family

ID=38198404

Family Applications (2)

Application Number Title Priority Date Filing Date
ES11185914T Active ES2530623T3 (es) 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica
ES07819835T Active ES2403584T3 (es) 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para reducir los niveles de triglicéridos, colesterol y glucosa

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES07819835T Active ES2403584T3 (es) 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para reducir los niveles de triglicéridos, colesterol y glucosa

Country Status (23)

Country Link
US (2) US8198310B2 (enExample)
EP (2) EP2097080B1 (enExample)
JP (1) JP5192490B2 (enExample)
KR (1) KR101413616B1 (enExample)
CN (1) CN101541323B (enExample)
AR (1) AR063894A1 (enExample)
AU (1) AU2007323351B2 (enExample)
BR (1) BRPI0718522A2 (enExample)
CA (1) CA2666371C (enExample)
CY (1) CY1116664T1 (enExample)
DK (2) DK2097080T3 (enExample)
EA (1) EA016885B1 (enExample)
ES (2) ES2530623T3 (enExample)
GE (1) GEP20125570B (enExample)
IL (1) IL198286A (enExample)
IT (1) ITMI20062254A1 (enExample)
MX (1) MX2009004295A (enExample)
PL (2) PL2409698T3 (enExample)
PT (2) PT2409698E (enExample)
SG (1) SG176508A1 (enExample)
SI (2) SI2097080T1 (enExample)
UA (1) UA97123C2 (enExample)
WO (1) WO2008061671A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
SG176885A1 (en) 2009-08-03 2012-01-30 Acraf Process for the preparation of 1-benzyl-3-hydr0xymethyl-1h-indaz0le and its derivatives and required magnesium intermediates
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2015173786A1 (en) * 2014-05-15 2015-11-19 Boyd Shelley Romayne Compositions and methods for treating and diagnosing ocular disorders
EP3990433B1 (en) 2019-06-25 2026-05-20 Translatum Medicus Inc PROCESSES FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
EP4171736A4 (en) 2020-06-27 2024-07-03 Crescenta Biosciences NEW CELL METABOLISM MODULATING COMPOUNDS AND THEIR USES
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131779B (it) * 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1230441B (it) 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
IT1293794B1 (it) 1997-07-28 1999-03-10 Acraf Farmaco attivo nel ridurre la produzione di proteina mcp-1
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
EP2823812A1 (en) * 1998-02-02 2015-01-14 Trustees Of Tufts College Dipeptidylpeptidase IV inhibitors for use in the treatment of Type II diabetes
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
ITFI20010230A1 (it) * 2001-11-29 2003-05-29 Menarini Int Operations Lu Sa Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
US20060030582A1 (en) * 2002-04-29 2006-02-09 Demartino Julie Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
WO2006117316A1 (en) * 2005-04-29 2006-11-09 Nycomed Gmbh Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity
CA2671539A1 (en) * 2005-12-01 2007-06-07 Flinders Technologies Pty Ltd Methods and compositions for preventing and/or treating pancreatitis
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca

Also Published As

Publication number Publication date
EP2097080B1 (en) 2013-02-20
GEP20125570B (en) 2012-07-10
US20120283307A1 (en) 2012-11-08
EA016885B1 (ru) 2012-08-30
IL198286A0 (en) 2010-02-17
PL2409698T3 (pl) 2015-06-30
CN101541323B (zh) 2012-01-04
US8198310B2 (en) 2012-06-12
ES2403584T3 (es) 2013-05-20
ITMI20062254A1 (it) 2008-05-25
AR063894A1 (es) 2009-02-25
BRPI0718522A2 (pt) 2013-11-12
AU2007323351B2 (en) 2013-05-02
US20100069456A1 (en) 2010-03-18
WO2008061671A3 (en) 2008-11-27
PT2097080E (pt) 2013-04-01
SI2409698T1 (sl) 2015-04-30
HK1129071A1 (en) 2009-11-20
SI2097080T1 (sl) 2013-05-31
WO2008061671A2 (en) 2008-05-29
KR101413616B1 (ko) 2014-07-01
JP5192490B2 (ja) 2013-05-08
IL198286A (en) 2016-03-31
US8846745B2 (en) 2014-09-30
CA2666371C (en) 2014-05-06
AU2007323351A1 (en) 2008-05-29
EP2409698A1 (en) 2012-01-25
EA200970506A1 (ru) 2009-10-30
UA97123C2 (uk) 2012-01-10
CY1116664T1 (el) 2017-03-15
MX2009004295A (es) 2009-05-05
SG176508A1 (en) 2011-12-29
PL2097080T3 (pl) 2013-07-31
KR20090081410A (ko) 2009-07-28
EP2097080A2 (en) 2009-09-09
DK2409698T3 (en) 2015-04-27
CN101541323A (zh) 2009-09-23
EP2409698B1 (en) 2015-01-21
DK2097080T3 (da) 2013-05-21
JP2010510263A (ja) 2010-04-02
HK1165275A1 (en) 2012-10-05
PT2409698E (pt) 2015-02-10
CA2666371A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
ES2530622T3 (es) Dispositivo para la correcta colocación de baldosas
USD609602S1 (en) Coupler fitting for an artificial tree segment
USD640904S1 (en) Wine aerator
USD540194S1 (en) Container
PE20120596A1 (es) Recipiente de llenado en caliente
USD621918S1 (en) Water closet
WO2011081656A3 (en) Refill, adapter for a refill, and method of retaining a refill
USD615635S1 (en) Plumbing fixture
EP1945069A4 (en) VERTICAL TOOL BEARING DEVICE WITH A BENT HANDLE
USD562929S1 (en) Water dispensing device
WO2008154975A8 (de) Ultraschall-füllstandsmessvorrichtung mit grenzstandserkennung
USD621239S1 (en) Upper beam slab bolster
CA2690946A1 (en) Nipple for feeding liquids to calves and other mammals
DE602005011326D1 (de) Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
CL2013000502A1 (es) Compuestos derivados de-2-(1-(2(2carbonil - etil) bencil) pirrolidin-2il)-n- alquiloxazol -4 carboxamida; uso en el tratamiento de enfermedades involucrada con la respuesta anttinflamatoria en receptores de prostaglandina.
CN202277846U (zh) 多功能试管架
CN201303541Y (zh) 一种猪用采食器
CN201379263Y (zh) 氧气表、湿化瓶存放支架
FR2918071B1 (fr) Procede d'incorporation d'alcool dans les carburants
CN202069350U (zh) 一种防倾倒杯托
USD687935S1 (en) Urine-splatter preventing inverted flush able funnels and their storage box
CN204448659U (zh) 一种金链喷洗池
CN204118620U (zh) 一种双接头的防水防爆过路盒
IT1397254B1 (it) Elettrolizzatore a cella "nucleo-guscio" con nucleo a base di materiali dielettrici a bassa permittivita'.
USD638093S1 (en) Fishing rod tip orifice